NCT05503953CompletedPhase 3
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
A multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients with Essential Hypertension Inadequately Controlled with AGLS
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 318 (actual)
- First submitted
- 15 Aug 2022
- Start date
- 13 Sept 2022
- Primary completion date
- 10 Jun 2025
- Lead sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Diseases
- High blood pressure
- NCT number
- NCT05503953
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 318
- From 13 Sept 2022 to the primary completion date, 10 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who have received 4 or more antihypertensive drug
Other illness
- Patient with secondary hypertension(including past medical history)
Other
- Patient with 20mmHg\>= of difference in MSSBP or 10mmHg\>= of difference in MSDBP BP measuring at Visit 1
- Patient with MSDBP \>= 120mmHg at Visit 1 and 2
Who the study is looking for
- Hypertension patient who satisfied below condition at Visit 1.
- patient who takes antihypertensive drug
- 140mmHg \<= MSSBP \< 200mmHg
- 130mmHg \<= MSSBP \< 200mmHg at or before visit 1(In high-risk patients)
- patient who doesn't take antihypertensive drug
- 160mmHg \<= MSSBP \< 200mmHg
- Hypertension patient who satisfied below condition at Visit 2.
- 140mmHg \<= MSSBP \< 200mmHg at Visit 2
- 130mmHg \<= MSSBP \< 200mmHg at or before Visit 1(In high-risk patients)
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AhnGook Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.